In the case of cancers, tumors have overexpression of the PD-L1 to evade the immune system, which increases the possibility of tumorigenesis and invasiveness, making malignant cells less susceptible to specific CD8+ T cell-mediated lysis. Here, CD8A is linked to cancer.